189 related articles for article (PubMed ID: 33989755)
1. Generation and analysis of 3D cell culture models for drug discovery.
Belfiore L; Aghaei B; Law AMK; Dobrowolski JC; Raftery LJ; Tjandra AD; Yee C; Piloni A; Volkerling A; Ferris CJ; Engel M
Eur J Pharm Sci; 2021 Aug; 163():105876. PubMed ID: 33989755
[TBL] [Abstract][Full Text] [Related]
2. Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting.
Anthon SG; Valente KP
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498908
[TBL] [Abstract][Full Text] [Related]
3. 3D bioprinting for drug discovery and development in pharmaceutics.
Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
[TBL] [Abstract][Full Text] [Related]
4. Application of standard cell cultures and 3D in vitro tissue models as an effective tool in drug design and development.
Amelian A; Wasilewska K; Megias D; Winnicka K
Pharmacol Rep; 2017 Oct; 69(5):861-870. PubMed ID: 28623710
[TBL] [Abstract][Full Text] [Related]
5. Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture.
Ryan SL; Baird AM; Vaz G; Urquhart AJ; Senge M; Richard DJ; O'Byrne KJ; Davies AM
Assay Drug Dev Technol; 2016; 14(1):19-28. PubMed ID: 26866750
[TBL] [Abstract][Full Text] [Related]
6. Cancer drug discovery: recent innovative approaches to tumor modeling.
Lovitt CJ; Shelper TB; Avery VM
Expert Opin Drug Discov; 2016 Sep; 11(9):885-94. PubMed ID: 27454169
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for simplifying HTS 3D cell culture platforms for drug discovery: the case for cytokines.
Lai Y; Asthana A; Kisaalita WS
Drug Discov Today; 2011 Apr; 16(7-8):293-7. PubMed ID: 21277382
[TBL] [Abstract][Full Text] [Related]
8. Organ-on-chip models: Implications in drug discovery and clinical applications.
Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
[TBL] [Abstract][Full Text] [Related]
9. Advances in microfluidic 3D cell culture for preclinical drug development.
Russo M; Cejas CM; Pitingolo G
Prog Mol Biol Transl Sci; 2022; 187(1):163-204. PubMed ID: 35094774
[TBL] [Abstract][Full Text] [Related]
10. 3D Bioprinting and Its Application to Military Medicine.
Betz JF; Ho VB; Gaston JD
Mil Med; 2020 Sep; 185(9-10):e1510-e1519. PubMed ID: 32514549
[TBL] [Abstract][Full Text] [Related]
11. Human iPS Cell-Derived Patient Tissues and 3D Cell Culture Part 1: Target Identification and Lead Optimization.
Eglen RM; Reisine T
SLAS Technol; 2019 Feb; 24(1):3-17. PubMed ID: 30286296
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional cell culture: the missing link in drug discovery.
Breslin S; O'Driscoll L
Drug Discov Today; 2013 Mar; 18(5-6):240-9. PubMed ID: 23073387
[TBL] [Abstract][Full Text] [Related]
13. A novel three-dimensional cell culture method enhances antiviral drug screening in primary human cells.
Koban R; Neumann M; Daugs A; Bloch O; Nitsche A; Langhammer S; Ellerbrok H
Antiviral Res; 2018 Feb; 150():20-29. PubMed ID: 29224735
[TBL] [Abstract][Full Text] [Related]
14. Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development.
Jung O; Song MJ; Ferrer M
SLAS Discov; 2021 Oct; 26(9):1164-1176. PubMed ID: 34269079
[TBL] [Abstract][Full Text] [Related]
15. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
Struzyna LA; Watt ML
Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
[TBL] [Abstract][Full Text] [Related]
17. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
18. Drug screening for human genetic diseases using iPSC models.
Elitt MS; Barbar L; Tesar PJ
Hum Mol Genet; 2018 Aug; 27(R2):R89-R98. PubMed ID: 29771306
[TBL] [Abstract][Full Text] [Related]
19. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
Nam KH; Smith AS; Lone S; Kwon S; Kim DH
J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
[TBL] [Abstract][Full Text] [Related]
20. Bioprinting towards Physiologically Relevant Tissue Models for Pharmaceutics.
Peng W; Unutmaz D; Ozbolat IT
Trends Biotechnol; 2016 Sep; 34(9):722-732. PubMed ID: 27296078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
